134 related articles for article (PubMed ID: 31239768)
21. Upregulation of Caveolin-1 correlate with Akt expression and poor prognosis in NPC patients.
Wang YP; Lin CF; Tsai SC; Tsai CH; Yeh TH
Laryngoscope; 2015 Jul; 125(7):E231-8. PubMed ID: 25877996
[TBL] [Abstract][Full Text] [Related]
22. Protein expression of hypoxia-inducible factor-1 alpha and hepatocellular carcinoma: a systematic review with meta-analysis.
Cao S; Yang S; Wu C; Wang Y; Jiang J; Lu Z
Clin Res Hepatol Gastroenterol; 2014 Oct; 38(5):598-603. PubMed ID: 24835771
[TBL] [Abstract][Full Text] [Related]
23. Liver transplantation in cirrhotic patients with small hepatocellular carcinoma: an analysis of pre-operative imaging, explant histology and prognostic histologic indicators.
Bhattacharjya S; Bhattacharjya T; Quaglia A; Dhillon AP; Burroughs AK; Patch DW; Tibballs JM; Watkinson AF; Rolles K; Davidson BR
Dig Surg; 2004; 21(2):152-9; discussion 159-60. PubMed ID: 15166485
[TBL] [Abstract][Full Text] [Related]
24. High expression of miR-21 is not a predictor of poor prognosis in all patients with hepatocellular carcinoma.
Yi PS; Li JS
Mol Clin Oncol; 2018 Jun; 8(6):733-739. PubMed ID: 29732156
[TBL] [Abstract][Full Text] [Related]
25. The Prognostic Significance of NEK2 in Hepatocellular Carcinoma: Evidence from a Meta-Analysis and Retrospective Cohort Study.
Cheng Y; Chen X; Ye L; Zhang Y; Liang J; Liu W; Zhou B; Zheng S; Huang Y; Chen G; Deng Y; Zhang Q; Yang Y
Cell Physiol Biochem; 2018; 51(6):2746-2759. PubMed ID: 30562736
[TBL] [Abstract][Full Text] [Related]
26. Hypoxia inducible factor 1α in hepatocellular carcinoma with cirrhosis: Association with prognosis.
Wang D; Zhang X; Lu Y; Wang X; Zhu L
Pathol Res Pract; 2018 Dec; 214(12):1987-1992. PubMed ID: 30274686
[TBL] [Abstract][Full Text] [Related]
27. Progesterone receptor membrane component 1 as a potential prognostic biomarker for hepatocellular carcinoma.
Tsai HW; Ho CL; Cheng SW; Lin YJ; Chen CC; Cheng PN; Yen CJ; Chang TT; Chiang PM; Chan SH; Ho CH; Chen SH; Wang YW; Chow NH; Lin JC
World J Gastroenterol; 2018 Mar; 24(10):1152-1166. PubMed ID: 29563759
[TBL] [Abstract][Full Text] [Related]
28. Cyclin-Dependent Kinase Regulatory Subunit 2 Indicated Poor Prognosis and Facilitated Aggressive Phenotype of Hepatocellular Carcinoma.
Zhang J; Song Q; Liu J; Lu L; Xu Y; Zheng W
Dis Markers; 2019; 2019():8964015. PubMed ID: 31781310
[TBL] [Abstract][Full Text] [Related]
29. Prognostic and clinicopathologic significance of SIRT1 expression in hepatocellular carcinoma.
Jiang H; Zhang X; Tao Y; Shan L; Jiang Q; Yu Y; Cai F; Ma L
Oncotarget; 2017 Aug; 8(32):52357-52365. PubMed ID: 28881735
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of p53 overexpression after hepatic resection of hepatocellular carcinoma.
Sung CO; Yoo BC; Koh KC; Cho JW; Park CK
Korean J Gastroenterol; 2005 Jun; 45(6):425-30. PubMed ID: 15973077
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of caveolin-1 in genitourinary cancer: a meta-analysis.
Liu JM; Cheng SH; Liu XX; Xia C; Wang WW; Ma XL
Int J Clin Exp Med; 2015; 8(11):20760-8. PubMed ID: 26884999
[TBL] [Abstract][Full Text] [Related]
32. A meta-analysis for C-X-C chemokine receptor type 4 as a prognostic marker and potential drug target in hepatocellular carcinoma.
Hu F; Miao L; Zhao Y; Xiao YY; Xu Q
Drug Des Devel Ther; 2015; 9():3625-33. PubMed ID: 26203228
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of Notch-1 expression in hepatocellular carcinoma: a meta-analysis.
Wu T; Jiao M; Jing L; Wang MC; Sun HF; Li Q; Bai YY; Wei YC; Nan KJ; Guo H
Onco Targets Ther; 2015; 8():3105-14. PubMed ID: 26543379
[TBL] [Abstract][Full Text] [Related]
34. [Relationship between expression of caveolin-1 and pERK1/2 and prognosis in non-small cell lung cancer].
Liu HX; Xing LX; Wang HB; Yang JQ; Sun YM
Zhonghua Bing Li Xue Za Zhi; 2008 Sep; 37(9):615-9. PubMed ID: 19094586
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of cytokeratin 19 in hepatocellular carcinoma: A meta-analysis.
Sun DW; Zhang YY; Sun XD; Chen YG; Qiu W; Ji M; Lv GY
Clin Chim Acta; 2015 Aug; 448():161-9. PubMed ID: 26164382
[TBL] [Abstract][Full Text] [Related]
36. Prognostic and clinicopathological significance of MACC1 expression in hepatocellular carcinoma patients: a meta-analysis.
Sun DW; Zhang YY; Qi Y; Liu GQ; Chen YG; Ma J; Lv GY
Int J Clin Exp Med; 2015; 8(4):4769-77. PubMed ID: 26131051
[TBL] [Abstract][Full Text] [Related]
37. Transferrin receptor 1 overexpression is associated with tumour de-differentiation and acts as a potential prognostic indicator of hepatocellular carcinoma.
Adachi M; Kai K; Yamaji K; Ide T; Noshiro H; Kawaguchi A; Aishima S
Histopathology; 2019 Jul; 75(1):63-73. PubMed ID: 30811632
[TBL] [Abstract][Full Text] [Related]
38. Impaired phosphate and tension homologue deleted on chromosome 10 expression and its prognostic role in radical surgery for hepatocellular carcinoma with family aggregation resulting from hepatitis B and liver cirrhosis.
Zhong Y; Yan J; Deng M; Hu K; Yao Z; Zou Y; Xu R
Exp Biol Med (Maywood); 2013 Aug; 238(8):866-73. PubMed ID: 23828588
[TBL] [Abstract][Full Text] [Related]
39. Loss of p57 expression and RhoA overexpression are associated with poor survival of patients with hepatocellular carcinoma.
Hu T; Guo H; Wang W; Yu S; Han L; Jiang L; Ma J; Yang C; Guo Q; Nan K
Oncol Rep; 2013 Oct; 30(4):1707-14. PubMed ID: 23842948
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of eukaryotic initiation factor 4E in hepatocellular carcinoma.
Jiang XM; Yu XN; Huang RZ; Zhu HR; Chen XP; Xiong J; Chen ZY; Huang XX; Shen XZ; Zhu JM
J Cancer Res Clin Oncol; 2016 Nov; 142(11):2309-17. PubMed ID: 27601163
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
